Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

The development of a robust and safe anticancer therapy based on TNF and interferon

Outputs and Outcomes

Code

365N3410

Duration

01 January 2011 → 31 December 2011

Funding

Funding by bilateral agreement (private and foundations)

Promotor

Claude Libert

Research disciplines

Medical and health sciences
- Gastro-enterology and hepatology
- Immunology
- Morphological sciences
- Oncology
- Respiratory medicine
- Gastro-enterology and hepatology
- Immunology
- Morphological sciences
- Oncology
- Respiratory medicine
- Gastro-enterology and hepatology
- Immunology
- Morphological sciences
- Oncology
- Respiratory medicine

Keywords

cytokines cancer therapy

Project description

The anticancer activity of a TNF and IFNg combination is well known, but the toxicity of the treatment is problematic. In this project, we investigate if we can find a solution to this dilemma.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by